Reviva Pharmaceuticals Holdings Inc (RVPH)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Reviva Pharmaceuticals Holdings Inc Azioni (RVPH) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	33.64% 4.0298	6.073	6.5382	6.2846	8.4625
Operating Income/Loss	33.64% -4.0298	-6.073	-6.5382	-6.2846	-8.4625
Nonoperating Income/Loss	19.83% 0.0219	0.0273	0.1105	0.0299	0.0967
Income/Loss From Continuing Operations Before Tax	33.71% -4.0079	-6.0457	-6.4276	-6.2547	-8.3658
Income Tax Expense/Benefit	64.29% 0.00284	0.00795	0.00521	0.00473	-
Income/Loss From Continuing Operations After Tax	33.75% -4.0108	-6.0536	-6.4328	-6.2595	-8.3658
Net Income/Loss	33.75% -4.0108	-6.0536	-6.4328	-6.2595	-8.3658
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	45.82% 72.69	49.85	48.64	1.723	33.80
Basic Earnings Per Share	50.00% -0.06	-0.12	-0.13	-0.15	-0.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-